Variation in Risk-Standardized Acute Admission Rates Among Patients With Heart Failure in Accountable Care Organizations: Implications for Quality MeasurementJOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32023-07-040OAAI
The Association Between Beta-blocker and Renin-Angiotensin System Inhibitor Use After Heart Failure With Reduced Ejection Fraction Hospitalization and Outcomes in Older PatientsJOURNAL OF CARDIAC FAILUREIF8.22023-04-013OAAI
Estimation of Out-of-Pocket Costs for Guideline-Directed Medical Therapy for Heart Failure Under Medicare Part D and the Inflation Reduction ActJAMA CARDIOLOGYIF14.12023-03-0111OA
Real-world safety of neurohormonal antagonist initiation among older adults following a heart failure hospitalizationESC HEART FAILUREIF3.72023-02-203OA
The association between beta-blockers and outcomes in patients with heart failure and concurrent Alzheimer's disease and related dementiasJOURNAL OF THE AMERICAN GERIATRICS SOCIETYIF4.52022-10-144PRE
Sacubitril/valsartan vs ACEi/ARB at hospital discharge and 5-year survival in older patients with heart failure with reduced ejection fraction: A decision analysis approachAMERICAN HEART JOURNALIF3.52022-08-018PRE
Opposing forces of cardiogenic shock: left ventricular outflow obstruction, severe mitral regurgitation, and left ventricular dysfunction in Takotsubo cardiomyopathyESC HEART FAILUREIF3.72022-05-063OAAI
Heart failure and cognitive impairment: Complexity that requires a new approachJOURNAL OF THE AMERICAN GERIATRICS SOCIETYIF4.52022-04-152OA
Comparative effectiveness of cardiac resynchronization therapy in older patients with heart failure: Systematic review and meta-analysisJOURNAL OF CARDIAC FAILUREIF8.22022-03-013PRE
Reply to: Comment on: The association between neurohormonal therapy and mortality in older adults with HFrEFJOURNAL OF THE AMERICAN GERIATRICS SOCIETYIF4.52021-10-090OA
Association Between Diagnosis Code Expansion and Changes in 30-Day Risk-Adjusted Outcomes for Cardiovascular DiseasesJOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32021-08-173OAAI
The association between neurohormonal therapy and mortality in older adults with heart failure with reduced ejection fractionJOURNAL OF THE AMERICAN GERIATRICS SOCIETYIF4.52021-06-1510OAAI
Association Between Beta-Blockers and Mortality and Readmission in Older Patients with Heart Failure: an Instrumental Variable AnalysisJOURNAL OF GENERAL INTERNAL MEDICINEIF4.22021-06-0713OAAI
Inclusion of Performance Parameters and Patient Context in the Clinical Practice Guidelines for Heart FailureJOURNAL OF CARDIAC FAILUREIF8.22021-02-012OAAI
Evaluation of Hospital Performance Using the Excess Days in Acute Care Measure in the Hospital Readmissions Reduction ProgramANNALS OF INTERNAL MEDICINEIF15.22021-01-0119OAAI
Post-Discharge Beta-Blockers and Early Mortality and Readmission in Older Patients With Heart Failure: An Instrumental Variable AnalysisCIRCULATIONIF38.62020-11-170PRE
Impact of Medicare Diagnosis Code Expansion and Inclusion of Outpatient Data on Risk-adjusted 30-day Mortality and Readmission Rates After Acute Myocardial InfarctionCIRCULATIONIF38.62020-11-170PRE
Comparative Effectiveness of CRT in Older Patients With Heart Failure: Systematic Review and Meta-AnalysisCIRCULATIONIF38.62020-11-170PRE
Should Patients With Heart Failure With Reduced Ejection Fraction (HFrEF) be Discharged on Sacubitril/Valsartan or ACEi/ARB: A Decision Analysis ApproachCIRCULATIONIF38.62020-11-170PRE